Related Experiment Videos
Heart transplantation charges: status 1 versus status 2 patients
T V Votapka1, M T Swartz, J E Reedy
1Division of Cardiothoracic Surgery, St. Louis University Health Sciences Center, MO 63110-0250, USA.
Insights
Heart transplantation costs for status 1 patients are significantly higher than for status 2 patients. Future trends suggest increased status 1 transplants will double overall costs.
Area of Science:
- Cardiology
- Transplantation Medicine
- Health Economics
Background:
- Healthcare cost allocation requires scrutiny.
- Understanding heart transplantation costs is crucial.
- This study analyzes hospital and physician billing for orthotopic heart transplantation.
Purpose of the Study:
- To compare the financial costs and clinical outcomes of United Network for Organ Sharing (UNOS) status 1 and status 2 heart transplant recipients.
- To analyze the distribution of heart transplantation costs based on patient priority status.
Main Methods:
- Retrospective review of 107 consecutive orthotopic heart transplantations (August 1988 - September 1993).
- Comparison of charges and clinical results between UNOS status 1 (n=46) and status 2 (n=57) patients.
- Charges were adjusted to 1992 US dollars for consistent analysis.
Main Results:
- Status 1 patients had significantly longer hospitalizations (mean 49 days vs. 17.5 days) and higher pretransplantation charges (mean $109,116 vs. $250).
- Total charges were significantly higher for status 1 patients (mean $239,375) compared to status 2 patients (mean $128,594).
- The total study period cost of $18,341,108 could fund 77 status 1 or 143 status 2 transplants.
Conclusions:
- A shift towards prioritizing status 1 patients in heart transplantation is observed.
- Continuing trends indicate a future where most transplants are status 1, potentially doubling overall costs.
- Efficient resource allocation and donor pool management are critical for sustainable heart transplantation programs.
Background:
The current health care environment mandates closer scrutiny of health care dollar allocation. To better understand the distribution of heart transplantation costs, we reviewed hospital and physician billing of patients who underwent orthotopic heart transplantation between August 1988 and September 1993.
Methods:
This study is a retrospective review of 107 consecutive cases. Charges and clinical results of United Network for Organ Sharing status 1 patients (n = 46), including 17 bridge to transplantation patients, were compared with those of United Network for Organ Sharing status 2 patients (n = 57). Charges were converted to 1992 dollars.
Results:
During the first 12 months of the study, 77% of heart transplantations were performed in United Network for Organ Sharing status 2 patients, whereas over the last 12-month period, 25% of the transplantations were performed in status 2 patients. No significant differences were found in age, gender, type of cardiomyopathy, or survival between the status 1 and status 2 groups. The length of hospitalization for the status 1 group ranged from 8 to 138 days (mean 49 days) as opposed to 5 to 82 days (mean 17.5 days) for the status 2 group (p < 0.0001). Pretransplantation hospital charges were significantly higher for the status 1 group ($47,917 to $341,215, mean $109,116) when compared with status 2 ($0 to $10,035, mean $250) (p < 0.0001). No significant difference was found in posttransplantation hospital charges between status 1 ($47,917 to $210,027, mean $95,379) and status 2 patients ($48,093 to $380,745, mean $102,265). Total charges were significantly higher (p < 0.0001) for the status 1 group ($89,910 to $512,331, mean $239,375) when compared with the status 2 group ($63,885 to $455,680, mean $128,594). Total transplantation charges for the study period were $18,341,108. This amount could have paid for 77 status 1 transplantations or 143 status 2 transplantations.
Conclusions:
If current trends continue and the donor pool remains the same, most transplant recipients will be status 1, resulting in a comparable number of transplantations performed at twice the charges.